Background A complete remission is essential for prolongingsurvival in patients with acute myeloid leukemia (AML) Daunorubicinis a cornerstone of the induction regimen  but the optimal doseis unknown In older patients  it is usual to give daunorubicinat a dose of 45 to 50 mg per square meter of body-surface area